Adicet Bio, Inc.
ACET
$6.47
-$0.26-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.23% | 11.88% | -4.40% | -0.71% | 2.58% |
| Total Depreciation and Amortization | -9.24% | -1.19% | 3.31% | 1.76% | -3.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -61.54% | -100.00% |
| Total Other Non-Cash Items | 70.33% | -65.67% | -57.76% | -56.37% | -43.38% |
| Change in Net Operating Assets | 1,381.55% | 211.90% | 103.02% | 43.10% | 84.80% |
| Cash from Operations | 13.24% | -1.37% | -13.71% | -11.15% | -2.62% |
| Capital Expenditure | 105.68% | 47.88% | 84.44% | -524.27% | -29.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.99% | 117.72% | -- | -- | -- |
| Cash from Investing | -101.33% | 117.43% | 11,011.59% | -1,097.07% | -16,164.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 54,813.87% | -- | 30.88% | -- | -12.74% |
| Repurchase of Common Stock | -- | -- | -- | 26.24% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 54,813.87% | -- | 30.88% | -100.09% | 80.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.24% | 95.26% | 128.01% | -132.27% | -95.72% |